Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric T Fung

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2007
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced diseaseManuel Aivado, Dimitrios Spentzos, Ulrich Germing, et al.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Cancer Cell|November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detectionArash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2007
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced diseaseManuel Aivado, Dimitrios Spentzos, Ulrich Germing, et al.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Cancer Cell|November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detectionArash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Pageof 6